Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Conditions: Malignant Mesothelioma
Start Date: May 1, 2001
Phase: Phase II
Status: Active, not recruiting
NCT ID: NCT00024271
Study Type: Interventional
Intervention: Biological: recombinant interferon gamma|Drug: cisplatin|Drug: doxorubicin hydrochloride|Drug: gemcitabine hydrochloride|Drug: mitomycin C|Procedure: conventional surgery|Procedure: hyperthermia treatment|Radiation: radiation therapy
Study Design: Primary Purpose: Treatment
Results: No Results Available
Sponsors: Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI)
Ages: Adult|Senior
Enrollment: 0
Funded By: Other|NIH
First Received: September 13, 2001
End Date:
Last Updated: February 6, 2009
Last Verified: January 1, 2004

Mesothelioma
Lawsuit Evaluation

First Name
Last Name
Phone Number
Email
Zip Code
Details:
Please Include Diagnosis Date
Type The Number Below: